天弘恒生沪深港创新药精选50ETF发起联接C(014565)资产配置
| 序号 |
报告期 |
股票占净比(%) |
债券占净比(%) |
现金占净比(%) |
净资产(元) |
| 1 |
2025-03-31 |
2.26 |
0.14 |
5.72 |
219,771,773.29 |
| 2 |
2024-12-31 |
2.07 |
0.15 |
5.26 |
65,774,942.39 |
| 3 |
2024-09-30 |
4.05 |
0.27 |
6.12 |
75,057,729.46 |
| 4 |
2024-06-30 |
3.08 |
0.67 |
5.44 |
60,367,790.24 |
| 5 |
2024-03-31 |
3.18 |
- |
5.92 |
65,002,769.38 |
| 6 |
2023-12-31 |
2.80 |
0.12 |
5.41 |
87,359,895.28 |
| 7 |
2023-09-30 |
2.73 |
- |
6.87 |
63,996,766.49 |
| 8 |
2023-06-30 |
3.79 |
0.22 |
6.05 |
46,647,272.02 |
| 9 |
2023-03-31 |
2.37 |
- |
10.30 |
32,438,355.51 |
| 10 |
2022-12-31 |
1.80 |
0.41 |
6.35 |
24,459,541.49 |
| 11 |
2022-09-30 |
1.20 |
- |
6.03 |
20,216,684.00 |
微信公众号
证券之星APP
基本资料
